Clinical Research Directory
Browse clinical research sites, groups, and studies.
Genetic Information for Families After Tumor Testing Study
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
The purpose of this study is to develop and implement a methodology of digital tools paired with telemedicine to improve cascade testing for clinically significant germline mutations among family members of children with cancer who have a pathogenic or likely pathogenic(P/LP) germline variant in a cancer predisposition gene.
Official title: Genetic Information for Families After Tumor Testing (GIFTT) Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-04
Completion Date
2028-03
Last Updated
2026-04-08
Healthy Volunteers
Yes
Conditions
Interventions
Interactive Chatbot
The chatbot intervention will provide biological parents the option to complete pre-test education using an interactive chatbot as an alternative to remote counseling with a genetic counselor. This interactive chatbot will provide opportunities for longitudinal educational and information support, reminders for scheduling next steps, and the option to send specific questions to the genetic counseling team.
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States